Cancer Research UK logo.
SearchDonate
  • Search

A study of axitinib for kidney cancer (NAXIVA)

Overview

Cancer types:

Kidney cancer, Renal cell cancer

Status:

Closed

Phase:

Phase 2

Details

This study is looking at having axitinib before surgery for kidney cancer to help shrink the cancer or stop it growing. It is open to people who can have surgery to remove all, or part, of their cancer.

Recruitment start: 1 December 2017

Recruitment end: 30 November 2019

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Mr Grant Stewart

Supported by

Common Services Agency (CSA)

NHS National Services Scotland

Pfizer

Scottish Clinical Trials Research Unit (SCTRU)

Last reviewed: 10 Dec 2019

CRUK internal database number: 14833

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.